Esketamine for teens with severe depression and suicidal thoughts
Treatments studied
Part of Mental health clinical trials.
This trial tests if esketamine (a nasal spray) can quickly reduce symptoms of major depression and suicidal thoughts in teenagers who need urgent hospital care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with major depression (confirmed by a doctor)
- Severe suicidal thoughts at the start of the study
- Depression symptoms that are moderate to severe
- Doctor says you need to be in the hospital right now for safety
- Generally healthy based on physical exam and heart test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a ketamine injection under the skin (subcutaneous) can safely help teenagers with severe depression and suicidal thoughts or actions. It is for teens who are already receiving standard depression treatment but still have high symptom scores.
This study tests whether adding a low dose of esketamine (a type of anesthesia) to modified electroconvulsive therapy (ECT) helps treat severe depression in teenagers. It aims to see if this combination works better and is safer than ECT alone.
This study tests whether esketamine, a nasal spray for depression, can help adults whose depression has not improved with at least two other antidepressants. Participants continue their current treatment while receiving esketamine.
This study tests esketamine nasal spray versus a placebo in adults with depression that has not improved after trying at least two other antidepressants. It aims to see if the spray can help when standard pills have not worked.
This study tests whether a single dose of ketamine, given through an IV, can quickly reduce suicidal thoughts in teenagers who come to the emergency department. It aims to find a faster way to help teens in crisis.
This trial tests how treatment with esketamine affects metabolism in people with depression. It may help if you have not responded to at least two standard antidepressants.
Hear when a new Depressive Disorder, Major trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.